bf/NASDAQ:CARA_icon.png

COM:CARATHERAPEUTICS

Cara Therapeutics

  • Stock

Last Close

0.31

22/11 21:00

Market Cap

15.64M

Beta: -

Volume Today

508.47K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
11.96M
-
3.18M
73.45%
3.80M
19.70%
86K
97.74%
911K
959.30%
13.47M
1,378.49%
19.89M
47.64%
135.08M
579.28%
23.03M
82.95%
41.87M
81.81%
20.97M
49.92%
cost of revenue
7.27M
-
6.43M
11.46%
gross profit
11.96M
-
3.18M
73.45%
3.80M
19.70%
86K
97.74%
911K
959.30%
13.47M
1,378.49%
19.89M
47.64%
135.08M
579.28%
23.03M
82.95%
34.60M
50.26%
14.54M
57.99%
selling and marketing expenses
general and administrative expenses
3.52M
-
6.18M
75.80%
7.77M
25.71%
9.23M
18.83%
11.87M
28.58%
15.32M
29.04%
17.75M
15.83%
21.75M
22.56%
29.41M
35.22%
30.26M
2.88%
27.65M
8.62%
selling general and administrative expenses
3.52M
-
6.18M
75.80%
7.77M
25.71%
9.23M
18.83%
11.87M
28.58%
15.32M
29.04%
17.75M
15.83%
21.75M
22.56%
29.41M
35.22%
30.26M
2.88%
27.65M
8.62%
research and development expenses
8.69M
-
15.07M
73.49%
21.22M
40.83%
49.25M
132.10%
48.52M
1.48%
75.53M
55.66%
113.82M
50.69%
107.85M
5.24%
82.70M
23.32%
91.88M
11.10%
108.38M
17.96%
other expenses
361K
-
101K
72.02%
652K
545.54%
1.16M
77.30%
2.98M
157.79%
4.49M
50.67%
97K
97.84%
642K
561.86%
2.06M
221.03%
3.59M
73.99%
cost and expenses
12.20M
-
21.25M
74.16%
28.99M
36.43%
58.49M
101.74%
60.40M
3.27%
90.85M
50.43%
131.56M
44.81%
129.70M
1.42%
112.11M
13.56%
129.40M
15.42%
142.46M
10.09%
operating expenses
12.20M
-
21.25M
74.16%
28.99M
36.43%
58.49M
101.74%
60.40M
3.27%
90.85M
50.43%
131.56M
44.81%
129.70M
1.42%
112.11M
13.56%
122.14M
8.94%
136.03M
11.38%
interest expense
-3.76M
-
126K
103.35%
-248K
-
604K
343.55%
ebitda
-237K
-
-18.07M
7,525.32%
-25.19M
39.38%
-58.40M
131.86%
-59.48M
1.86%
-77.38M
30.09%
-111.68M
44.32%
5.59M
105.01%
-89.08M
1,692.47%
-87.53M
1.74%
-121.24M
38.50%
operating income
-237K
-
-18.07M
7,525.32%
-25.19M
39.38%
-58.40M
131.86%
-59.48M
1.86%
-77.38M
30.09%
-111.68M
44.32%
5.38M
104.82%
-89.08M
1,754.28%
-87.53M
1.74%
-121.50M
38.80%
depreciation and amortization
789K
-
783K
0.76%
839K
7.15%
1.47M
74.61%
495K
66.21%
370K
25.25%
198K
46.49%
209K
5.56%
248K
18.66%
248K
0%
259K
4.44%
total other income expenses net
-3.76M
-
126K
103.35%
101K
19.84%
652K
545.54%
1.16M
77.30%
2.98M
157.79%
4.49M
50.67%
2.33M
48.02%
642K
72.49%
2.06M
221.03%
2.98M
44.69%
income before tax
-3.99M
-
-17.95M
349.44%
-25.09M
39.79%
-57.75M
130.19%
-58.33M
1.01%
-74.40M
27.56%
-107.19M
44.07%
7.72M
107.20%
-88.44M
1,245.76%
-85.47M
3.35%
-118.51M
38.65%
income tax expense
-30K
-
-201K
570%
-397K
97.51%
-468K
17.88%
-204K
56.41%
-389K
90.69%
-816K
109.77%
-691K
15.32%
-248K
64.11%
-2.06M
731.05%
net income
-3.96M
-
-17.75M
347.77%
-24.69M
39.14%
-57.28M
132.00%
-58.13M
1.48%
-74.01M
27.33%
-106.37M
43.72%
8.41M
107.91%
-88.19M
1,148.67%
-83.41M
5.42%
-118.51M
42.08%
weighted average shs out
21.84M
-
20.97M
4.01%
24.62M
17.43%
27.28M
10.80%
31.20M
14.38%
35.89M
15.03%
42.67M
18.88%
47.41M
11.12%
50.72M
6.97%
53.65M
5.79%
54.15M
0.92%
weighted average shs out dil
21.84M
-
20.97M
4.01%
24.62M
17.43%
27.28M
10.80%
31.20M
14.38%
35.89M
15.03%
42.67M
18.88%
47.92M
12.29%
50.72M
5.85%
53.65M
5.79%
54.15M
0.92%
eps
-0.18
-
-0.85
372.22%
-1
17.65%
-2.10
110.00%
-1.86
11.43%
-2.06
10.75%
-2.49
20.87%
0.18
107.23%
-1.74
1,066.67%
-1.55
10.92%
-2.19
41.29%
epsdiluted
-0.18
-
-0.85
372.22%
-1
17.65%
-2.10
110.00%
-1.86
11.43%
-2.06
10.75%
-2.49
20.87%
0.18
107.23%
-1.74
1,066.67%
-1.55
10.92%
-2.19
41.29%

All numbers in (except ratios and percentages)